IL9 and non-small cell lung carcinoma: We next further characterized the cellular source of IL-9 in lung tissue from NSCLC patients and focused our analysis on IL-9 production by tumor infiltrating T cells (TIL) and performed double immunohistochemistry with anti-IL-9 and anti-CD3 antibodies in lung tissue arrays as in Figure 1B.